About Tenshi Pharmaceuticals Private Limited
Data last updated:
Tenshi Pharmaceuticals Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the diversified financial services segment of the financial services sector. It was incorporated on 01 July 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U70200KA2016PTC200180. Its GSTIN is 29AAXCS2968P2ZW (Karnataka). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹2,072.9 Cr and a paid-up capital of ₹442.82 Cr. It was formerly known as Sovizen Life Sciences Private Limited and Steriscience Private Limited. It is led by directors Shridhara Kela and Pudhucode Radhakrishnan Kannan.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Bangalore, Karnataka.
As per the financials filed for FY 2025, the company reported a revenue of ₹1,723.68 Cr, a growth of 61% compared to the previous year. For the same year it recorded a net profit of ₹5,506.69 Cr (net margin 319.5%) and EBITDA of ₹3,808.31 Cr (EBITDA margin 220.9%). Revenue has grown at a compounded annual rate (CAGR) of 85% over three years and 187% over five years.
The company has about 8 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Tenshi Life Sciences. As per MCA filings, the company has open charges of ₹1,898.35 Cr and satisfied charges of ₹1,392.25 Cr on record. Court records list 3 cases involving the company, including 2 filed by the company and 1 filed against it. The company has 17 deals on record (11 secondary share transfers, 5 funding rounds, 1 convertible or debt financing), with disclosed funding of ₹112.7 Cr; the latest was in March 2022. The company has 5 MSME Form 1 returns on record between 2023 and 2024, listing 20 overdue payments to 4 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website tenshi.co.in.
Company details
Name history
Tenshi Pharmaceuticals has undergone 2 name changes throughout its history. The company was previously known as Sovizen Life Sciences Private Limited, and Steriscience Private Limited. The current legal name is Tenshi Pharmaceuticals Private Limited.
| Company Name | Status |
|---|---|
| Tenshi Pharmaceuticals Private Limited | Current |
| Sovizen Life Sciences Private Limited | Previous |
| Steriscience Private Limited | Previous |
CIN history
Tenshi Pharmaceuticals has 3 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U70200KA2016PTC200180, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U70200KA2016PTC200180 | Current |
| U74999KA2016PTC094652 | Previous |
| U74999KA2016PTC200180 | Previous |
| U74999TN2016PTC128331 | Previous |
Contact details
Tenshi Pharmaceuticals Private Limited's registered office is in Bangalore, Karnataka.
- Social Media
- Registered AddressCepha Block First Floor Sy No 152/6, 154/16 Dorasani Palya Begur Hobli, Bangalore, Karnataka, India – 560076
- IndustryFinancial Services, Diversified Financial Services
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Tenshi Pharmaceuticals operates one associated brand: Tenshi Life Sciences. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Delivers advanced finished dosage pharmaceuticals using global infrastructure and quality systems. | tenshi.co.in |
Business activity
The main business activities of Tenshi Pharmaceuticals are administrative and support service activities and support service to organizations. In detail, this covers office administrative, office support and other business support activities and other support services to organizations. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| N | Administrative and support service activities | 82 | Office administrative, office support and other business support activities | |
| N | Support service to Organizations | N7 | Other support services to organizations |
To see the full business activity and turnover split of Tenshi Pharmaceuticals Private Limited, buy the company report.
Financials of Tenshi Pharmaceuticals Private Limited
FY 2025 filings availableTenshi Pharmaceuticals Private Limited reported revenue of ₹1,723.68 Cr (up 61% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 187% over five years, including 61% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹1,723.68 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3,808.31 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹5,506.69 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 220.9% | ||||
| Net Profit Margin | 319.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Tenshi Pharmaceuticals Private Limited, buy the company report.
Board of directors of Tenshi Pharmaceuticals Private Limited
Tenshi Pharmaceuticals has 2 current directors and 12 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shridhara Kela Also directs: Devicam Capital LLP | Director | 03 Jun 2024 | 2 Years 5 Months | Current |
| Pudhucode Radhakrishnan Kannan Also directs: Dvise Medtech Private Limited, Serovia Pharma Private Limited, Dvise Pharma Tech Private Limited and 4 more | Director | 17 Jun 2024 | 2 Years 4 Months | Current |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 03 Jul 2025 | 101129503 | Others | ₹75 Cr | Open | |
| 27 Jun 2025 | 101197556 | Others | ₹300 Cr | Open | |
| 24 Mar 2025 | 101080276 | Others | ₹200 Cr | Open | |
| 13 Mar 2025 | 101110714 | Others | ₹350 Cr | Open | |
| 17 Dec 2024 | 101062252 | Others | ₹18.2 Cr | Open |
To see the full charge records of Tenshi Pharmaceuticals Private Limited, buy the company report.
Total charge records: 27 View all charges
Deals & funding
Tenshi Pharmaceuticals Private Limited has 17 deals on record (11 secondary share transfers, 5 funding rounds, 1 convertible or debt financing), with disclosed funding of ₹112.7 Cr; the latest was in March 2022.
Deals on record (5 of 17)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2022 | Secondary share transfer | Undisclosed | Buyer: Tenshi Life Sciences Private Limited Seller: Six Rays Pharma Solutions LLP |
| Jun 2019 | Secondary share transfer | Undisclosed | Buyer: Tenshi Life Sciences Private Limited Seller: 4 individuals |
| May 2019 | Secondary share transfer | Undisclosed | Seller: Shasun Enterprises LLP , 3 individuals |
| Aug 2018 | Secondary share transfer | Undisclosed | Seller: Tenshi Life Sciences Private Limited |
| Jun 2018 | Secondary share transfer | Undisclosed | Seller: Abusha Investment & Management Services LLP , an individual |
To see the full deal history of Tenshi Pharmaceuticals Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Tenshi Pharmaceuticals Private Limited has 3 court cases on record: 2 filed by Tenshi Pharmaceuticals, 1 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| NCLT | 2 | 0 | 0 |
| High courts | 1 | 1 | 0 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Delhi | Arbitration matter | Filed against the company by Dhani Loans and Services Ltd | Disposed |
| NCLT, Chennai | Court case (C.P.(CAA)) | Filed by the company | Disposed |
| NCLT, Chennai | Court case (C.A.(CAA)) | Filed by the company | Disposed |
To see the full case history of Tenshi Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Tenshi Pharmaceuticals Private Limited has 5 MSME Form 1 returns on record between 2023 and 2024, listing 20 overdue payments to 4 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (4 of 4)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Skylark Information Technologies Private Limited | |||
| Ikyam Solutions Private Limited | |||
| Technocomerz | |||
| Twenty Two by 7 Solutions Private Limited |
To see the full MSME payment records of Tenshi Pharmaceuticals Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
GST
Tenshi Pharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAXCS2968P2ZW | Karnataka | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Tenshi Pharmaceuticals Private Limited, buy the company report.
Recent activity
Tenshi Pharmaceuticals Private Limited has 14 board changes on record since 2017: 2 appointments and 12 cessations. The latest: Shridhara Kela ceased to be Additional Director on 26 Dec 2024.
49 earlier events are in the company report.
Frequently asked questions
Tenshi Pharmaceuticals is an active private limited company based in Bangalore, Karnataka, India. The company works in diversified financial services, within the financial services industry. It was incorporated on 01 July 2016 (10+ years old) and is registered under CIN U70200KA2016PTC200180.
Tenshi Pharmaceuticals has 2 current directors:
- Shridhara Kela - Director
- Pudhucode Radhakrishnan Kannan - Director
The latest financial statements of Tenshi Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Tenshi Pharmaceuticals is 29AAXCS2968P2ZW, registered in Karnataka. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Tenshi Pharmaceuticals is U70200KA2016PTC200180. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Tenshi Pharmaceuticals has 3 court cases on record: 2 filed by the company and 1 filed against it. Most are in the nclt.
Tenshi Pharmaceuticals was incorporated on 01 July 2016, making it 10+ years old. It is registered with the Registrar of Companies, Bangalore.
Tenshi Pharmaceuticals has 17 deals on record (11 secondary share transfers, 5 funding rounds, 1 convertible or debt financing), with disclosed funding of ₹112.7 Cr; the latest was in March 2022.
Shridhara Kela ceased to be Additional Director on 26 Dec 2024. Pudhucode Radhakrishnan Kannan was appointed as Director on 17 Jun 2024. Shridhara Kela was appointed as Director on 03 Jun 2024. Tenshi Pharmaceuticals has 14 board changes on record in total.
Tenshi Pharmaceuticals has 5 MSME Form 1 returns on record between 2023 and 2024, listing 20 overdue payments to 4 micro and small suppliers. The latest return was filed on 23 Apr 2024.
Tenshi Pharmaceuticals can be reached through the website tenshi.co.in. Its registered office is in Bangalore, Karnataka, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
